Green Thumb Industries (GTBIF) and Its Rivals Head to Head Survey

Green Thumb Industries (OTCMKTS:GTBIF) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its rivals? We will compare Green Thumb Industries to similar businesses based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, risk and earnings.

Valuation & Earnings

This table compares Green Thumb Industries and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Green Thumb Industries	$1.18 billion	$114.15 million	15.66
Green Thumb Industries Competitors	$1.89 billion	$136.81 million	5.75

Green Thumb Industries’ rivals have higher revenue and earnings than Green Thumb Industries. Green Thumb Industries is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Green Thumb Industries and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Green Thumb Industries	7.94%	5.24%	3.50%
Green Thumb Industries Competitors	-304.20%	-315.07%	-22.11%

Analyst Ratings

This is a summary of current ratings and recommmendations for Green Thumb Industries and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Green Thumb Industries	0	0	1	0	3.00
Green Thumb Industries Competitors	4290	10574	18359	830	2.46

Green Thumb Industries currently has a consensus price target of $18.00, suggesting a potential upside of 173.61%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.43%. Given Green Thumb Industries’ stronger consensus rating and higher possible upside, equities analysts clearly believe Green Thumb Industries is more favorable than its rivals.

Volatility & Risk

Green Thumb Industries has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Green Thumb Industries’ rivals have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Insider and Institutional Ownership

0.1% of Green Thumb Industries shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 9.4% of Green Thumb Industries shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Green Thumb Industries beats its rivals on 7 of the 13 factors compared.

Green Thumb Industries Company Profile

Green Thumb Industries is a U.S. cannabis company that cultivates and processes cannabis, manufactures consumer products, and sells products through wholesale channels and its retail stores. Its portfolio includes brands such as RYTHM, Dogwalkers and incredibles, with products including flower, pre-rolls, concentrates and edibles. The company was founded in 2014 and is headquartered in Chicago, Illinois. It serves cannabis markets in multiple U.S. states, with operations spanning cultivation, manufacturing and retail under the RISE dispensary name.